John M Maris
John M Maris
Professor Pediatrics, Children's Hospital of Philadelphia and University of Pennsylvania
Verified email at chop.edu
Title
Cited by
Cited by
Year
Recent advances in neuroblastoma
JM Maris
New England Journal of Medicine 362 (23), 2202-2211, 2010
14682010
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma
AL Yu, AL Gilman, MF Ozkaynak, WB London, SG Kreissman, HX Chen, ...
New England Journal of Medicine 363 (14), 1324-1334, 2010
13492010
Identification of ALK as a major familial neuroblastoma predisposition gene
YP Mossť, M Laudenslager, L Longo, KA Cole, A Wood, EF Attiyeh, ...
Nature 455 (7215), 930-935, 2008
12772008
Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia
WJ Song, MG Sullivan, RD Legare, S Hutchings, X Tan, D Kufrin, ...
Nature genetics 23 (2), 166-175, 1999
11111999
The genetic landscape of high-risk neuroblastoma
TJ Pugh, O Morozova, EF Attiyeh, S Asgharzadeh, JS Wei, D Auclair, ...
Nature genetics 45 (3), 279-284, 2013
7962013
Molecular biology of neuroblastoma
JM Maris, KK Matthay
Journal of clinical oncology 17 (7), 2264-2264, 1999
7291999
Convergence of acquired mutations and alternative splicing of CD19 enables resistance to CART-19 immunotherapy
E Sotillo, DM Barrett, KL Black, A Bagashev, D Oldridge, G Wu, ...
Cancer discovery 5 (12), 1282-1295, 2015
6832015
Chromosome 1p and 11q deletions and outcome in neuroblastoma
EF Attiyeh, WB London, YP Mossť, Q Wang, C Winter, D Khazi, ...
New England Journal of Medicine 353 (21), 2243-2253, 2005
5892005
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
YP Mossť, MS Lim, SD Voss, K Wilner, K Ruffner, J Laliberte, D Rolland, ...
The lancet oncology 14 (6), 472-480, 2013
5852013
Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1
KE Nichols, JD Crispino, M Poncz, JG White, SH Orkin, JM Maris, ...
Nature genetics 24 (3), 266-270, 2000
5392000
Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia
M Bentires-Alj, JG Paez, FS David, H Keilhack, B Halmos, K Naoki, ...
Cancer research 64 (24), 8816-8820, 2004
4972004
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group
WB London, RP Castleberry, KK Matthay, AT Look, RC Seeger, ...
Journal of clinical oncology 23 (27), 6459-6465, 2005
4882005
Control of oxidative metabolism and oxygen delivery in human skeletal muscle: a steady-state analysis of the work/energy cost transfer function
B Chance, JS Leigh, BJ Clark, J Maris, J Kent, S Nioka, D Smith
Proceedings of the National Academy of Sciences 82 (24), 8384-8388, 1985
4371985
Malignant pheochromocytoma: current status and initiatives for future progress
G Eisenhofer, SR Bornstein, FM Brouwers, NKV Cheung, PL Dahia, ...
Endocrine-related cancer 11 (3), 423-436, 2004
4302004
The pediatric preclinical testing program: description of models and early testing results
PJ Houghton, CL Morton, C Tucker, D Payne, E Favours, C Cole, ...
Pediatric blood & cancer 49 (7), 928-940, 2007
4232007
Chemoreduction in the initial management of intraocular retinoblastoma
CL Shields, P De Potter, BP Himelstein, JA Shields, AT Meadows, ...
Archives of Ophthalmology 114 (11), 1330-1338, 1996
4111996
Copy number variation at 1q21. 1 associated with neuroblastoma
SJ Diskin, C Hou, JT Glessner, EF Attiyeh, M Laudenslager, K Bosse, ...
Nature 459 (7249), 987-991, 2009
3872009
Comprehensive analysis of hypermutation in human cancer
BB Campbell, N Light, D Fabrizio, M Zatzman, F Fuligni, R de Borja, ...
Cell 171 (5), 1042-1056. e10, 2017
3852017
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
S Schlisio, RS Kenchappa, LCW Vredeveld, RE George, R Stewart, ...
Genes & development 22 (7), 884-893, 2008
3442008
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
PF Ambros, IM Ambros, GM Brodeur, M Haber, J Khan, A Nakagawara, ...
British journal of cancer 100 (9), 1471-1482, 2009
3362009
The system can't perform the operation now. Try again later.
Articles 1–20